Clinical trial
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a…
NCT00458302 · Janssen-Cilag International NV, Industry · Completed
Key facts
| NCT number | NCT00458302 |
|---|---|
| Title | Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir |
| Official title | A Randomised, Controlled, Open-label Trial to Compare the Efficacy, Safety and Tolerability of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg O.D. vs a Triple Combination Therapy With DRV/r in HIV-1 Infected Patients With Undetectable Plasma HIV-RNA on Their Current Treatments. |
| Acronym | MONET |
| Lead sponsor | Janssen-Cilag International NV, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, AIDS Virus, Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome Virus |
| Intervention type | Drug |
| Interventions | darunavir (DRV, TMC114) |
| Enrollment | 256 |
| Start date | Jun 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Jan 1, 2011 |
| First posted | Apr 10, 2007 |
| Last update posted | Dec 19, 2012 |
| Countries | Austria, Belgium, Denmark, Germany, Hungary, Israel, Portugal, Russia, Spain, Switzerland, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: